Concepedia

Mitomu Kioi

MK

Statistics

Publications

42

Citations

4.5K

H-Index

26

Active since

2003

Affiliations

Yokohama City University(Current)

Center for Biologics Evaluation and Research

Stanford University

National Cancer Institute

Food and Drug Administration

Mitomu Kioi is an author at Yokohama City University specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

2003–2021

42

Publications

42

SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

Eriko Michishita, Ronald A. McCord, Elisabeth Berber et al. · Nature · 2008 · 1.1K citations

, , +14

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice

Mitomu Kioi, Hannes Vogel, Geoffrey M. Schultz et al. · Journal of Clinical Investigation · 2010 · 758 citations · Full text

, , +16

SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation

Matthew F. Barber, Eriko Michishita-Kioi, Yuanxin Xi et al. · Nature · 2012 · 613 citations · Full text

, , +13

NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming

Alex Kuo, Peggie Cheung, Kaifu Chen et al. · Molecular Cell · 2011 · 442 citations · Full text

, , +9

Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model

Mitomu Kioi, Kazuhiro Yamamoto, Shouichi Higashi et al. · Oncogene · 2003 · 104 citations

, , +17

1–5 of 42